Potential hepatic stem cells reside in EpCAM+ cells of normal and injured mouse liver
Author:
Okabe Mayuko1, Tsukahara Yuko1, Tanaka Minoru1, Suzuki Kaori1, Saito Shigeru1, Kamiya Yoshiko1, Tsujimura Tohru2, Nakamura Koji3, Miyajima Atsushi1
Affiliation:
1. Laboratory of Cell Growth and Differentiation, Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo 113-0032, Japan. 2. Department of Pathology, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan. 3. LivTech, Miyamae-ku, Kawasaki, Kanagawa 216-0001, Japan.
Abstract
Hepatic oval cells are considered to be facultative hepatic stem cells(HSCs) that differentiate into hepatocytes and cholangiocytes in severely injured liver. Hepatic oval cells have also been implicated in tumorigenesis. However, their nature and origin remain elusive. To isolate and characterize mouse oval cells, we searched for cell surface molecules expressed on oval cells and analyzed their nature at the single-cell level by flow cytometric analysis and in the in vitro colony formation assay. We demonstrate that epithelial cell adhesion molecule (EpCAM) is expressed in both mouse normal cholangiocytes and oval cells, whereas its related protein, TROP2, is expressed exclusively in oval cells, establishing TROP2 as a novel marker to distinguish oval cells from normal cholangiocytes. EpCAM+ cells isolated from injured liver proliferate to form colonies in vitro, and the clonally expanded cells differentiate into hepatocytes and cholangiocytes,suggesting that the oval cell fraction contains potential HSCs. Interestingly,such cells with HSC characteristics exist among EpCAM+ cells of normal liver. Intriguingly, comparison of the colony formation of EpCAM+ cells in normal and injured liver reveals little difference in the number of potential HSCs, strongly suggesting that most proliferating mouse oval cells represent transit-amplifying cells rather than HSCs.
Publisher
The Company of Biologists
Subject
Developmental Biology,Molecular Biology
Reference75 articles.
1. Akhurst, B., Croager, E. J., Farley-Roche, C. A., Ong, J. K.,Dumble, M. L., Knight, B. and Yeoh, G. C. (2001). A modified choline-deficient, ethionine-supplemented diet protocol effectively induces oval cells in mouse liver. Hepatology34,519-522. 2. Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. and Clarke, M. F. (2003). Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA100,3983-3988. 3. Alison, M. R., Golding, M., Sarraf, C. E., Edwards, R. J. and Lalani, E. N. (1996). Liver damage in the rat induces hepatocyte stem cells from biliary epithelial cells. Gastroenterology110,1182-1190. 4. Apte, U., Thompson, M. D., Cui, S., Liu, B., Cieply, B. and Monga, S. P. (2008). Wnt/beta-catenin signaling mediates oval cell response in rodents. Hepatology47,288-295. 5. Armstrong, A. and Eck, S. L. (2003). EpCAM: A new therapeutic target for an old cancer antigen. Cancer Biol. Ther.2,320-326.
Cited by
240 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|